Who is sponsoring NCT04051892?

NCT04051892 is sponsored by FixNip Ltd.

What drugs are being tested in NCT04051892?

Interventions in NCT04051892: FixNip™ NRI.

What condition does NCT04051892 study?

NCT04051892 studies Reconstruction of the Breast Nipple and Areola Complex.

Is NCT04051892 still recruiting?

NCT04051892 is currently completed. Last updated 21 March 2023.

Last reviewed 2023-03-21 · How we verify

NCT04051892

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Multicenter Study Evaluating the FixNip™ NRI Safety and Performance

Completed NA Last updated 21 March 2023

What this trial tests

NA trial testing FixNip™ NRI in Reconstruction of the Breast Nipple and Areola Complex in 10 participants. Completed in 22 December 2022.

Timeline

6 October 2020

Primary endpoint
13 July 2022

22 December 2022

Quick facts

Lead sponsor	FixNip Ltd
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	other
Enrollment	10
Start date	6 October 2020
Primary completion	13 July 2022
Estimated completion	22 December 2022
Sites	1 location across Israel

Drugs / interventions tested

FixNip™ NRI

Conditions studied

Reconstruction of the Breast Nipple and Areola Complex — all drugs for Reconstruction of the Breast Nipple and Areola Complex →

Sponsor

FixNip Ltd

Who can join

Adults 22 to 70, female only, with Reconstruction of the Breast Nipple and Areola Complex. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A prospective, Open Label, Single arm, Multicenter study Evaluating the FixNip™ NRI Safety and Performance in Female Patients Seeking Reconstructive Surgery of the Nipple.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Nipple Reconstruction Using FixNip NRI: A Novel Nipple Reconstruction Implant (First-in-human Trial).
Konfino T, Scheflan LM, Caspi J, Stuchiner B, et al · · 2025 · cited 1× · PMID 40995572 · DOI 10.1097/gox.0000000000007103

Verify or expand the search:

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04051892 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by FixNip Ltd
Last refreshed: 21 March 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04051892.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing